Clinical Trials in Egypt / NCT07557524
Starting soon
Not applicable
Pulsed High Intensity Laser Versus Negative Pressure Therapy On Neuropathic Ulcers
NCT07557524 · tracked via the Priya Life Science Egypt tracker
Condition(s) studied
Neuropathic Ulcers
Investigational drug(s) / intervention(s)
Laser therapyNegative pressure therapy is applied to the negative pressure group
Laser therapy: Pulsed high intensity laser therapy is applied to wound bed
Negative pressure therapy is applied to the negative pressure group: It will be applied to patients with chronic wound
Study summary
the study comparess between laser therapy and vac to decide which on is superior
Eligibility
Inclusion Criteria:
\-
The subject selection will be according to the following criteria:
1. Ages of patients will be ranged from 40 to 60 years.
2. All patients have grade one, two and three neuropathic wound.
3. Both male and female are included.
Exclusion Criteria:
The potential participants will be excluded if they meet one of the following criteria:
1. Patient with untreated osteomyelitis.
2. Patients with active bleeding.
3. Patients with prescription of anticoagulant.
4. Patients with associated bone fractures.
5. Patients with malignancy.
6. Patients with diminished cognitive capacity.
Primary outcome measure(s)
- wound surface area — one month
imitoMeasure Mobil application: The ImitoMeasure app is a noncontact digital planimetry application that measures wound surface area and offers an advantage over other methods. The introduction of smartphones with high-definition cameras. These devices are not only portable and inexpensive, but they also provide the convenience of on-the-spot assessments.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| ELshiek Zayed spicilized hospital | Giza | Egypt |
More Cairo University trials in Egypt
The Link Between Periodontitis, Smoking and Oral Cancer
Starting soon
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07557524 on ClinicalTrials.gov ↗ ← All trials in Egypt